Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes

PURPOSE: The current clinical classification of pancreatic ductal adenocarcinoma (PDAC) cannot well predict the patient’s possible response to the treatment plan, nor can it predict the patient’s prognosis. We use the gene expression patterns of PDAC patients to reveal the heterogeneity of the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqin, Li, Lifang, Yang, Yang, Fan, Linlin, Ma, Ying, Mao, Feifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891159/
https://www.ncbi.nlm.nih.gov/pubmed/35252003
http://dx.doi.org/10.3389/fonc.2022.832715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891159/
https://www.ncbi.nlm.nih.gov/pubmed/35252003
http://dx.doi.org/10.3389/fonc.2022.832715

Ejemplares similares